Mostrar el registro sencillo

dc.contributor.authorOcampo Sosa, Alain Antonio
dc.contributor.authorGuzmán Gómez, Laura P.
dc.contributor.authorFernández Martínez, Marta
dc.contributor.authorRomán, Elena
dc.contributor.authorRodríguez Antona, Cristina
dc.contributor.authorMarco Reverté, Francesc
dc.contributor.authorVila Estapé, Jordi
dc.contributor.authorMartínez Martínez, Luis 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2015-11-05T11:46:24Z
dc.date.available2015-11-05T11:46:24Z
dc.date.issued2015-02
dc.identifier.issn1098-6596
dc.identifier.urihttp://hdl.handle.net/10902/7486
dc.description.abstractWe describe here the occurrence of blaVIM-2 in 10 carbapenem-resistant Pseudomonas monteilii strains isolated from different clinical samples from patients at the University Hospital Marqués de Valdecilla in northern Spain. All the blaVIM-2-harboring P. monteilii isolates possessed a class 1 integron, with the cassette array [intI1_blaVIM-2_aac(6')-Ib_qacEΔ1_sul1]. Our results show the emergence of VIM-2-producing multidrug-resistant species other than Pseudomonas aeruginosa or Pseudomonas putida in a Spanish hospital. P. monteilii, although sporadically isolated, should also be considered an important metallo-β-lactamase (MBL) reservoir.es_ES
dc.format.extent3 p.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiologyes_ES
dc.rights© American Society for Microbiologyes_ES
dc.sourceAntimicrobial Agents and Chemotherapy. 2015 Feb;59(2):1334-6es_ES
dc.titleIsolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in northern Spaines_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1128/AAC.04639-14
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo